Omega-3-acid ethyl esters type a - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for omega-3-acid ethyl esters type a and what is the scope of freedom to operate?
Omega-3-acid ethyl esters type a
is the generic ingredient in one branded drug marketed by Osmotica Pharm Us and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for omega-3-acid ethyl esters type a
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 5 |
Clinical Trials: | 73 |
DailyMed Link: | omega-3-acid ethyl esters type a at DailyMed |
Recent Clinical Trials for omega-3-acid ethyl esters type a
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Cancer Institute (NCI) | Phase 2 |
The University of Texas Health Science Center at San Antonio | Early Phase 1 |
National Center for Advancing Translational Sciences (NCATS) | Early Phase 1 |
US Patents and Regulatory Information for omega-3-acid ethyl esters type a
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Osmotica Pharm Us | OMTRYG | omega-3-acid ethyl esters type a | CAPSULE;ORAL | 204977-001 | Apr 23, 2014 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |